The Advisory Board Company (ABCO) Insider Sells $35,527.50 in Stock

The Advisory Board Company (NASDAQ:ABCO) insider Cormac F. Miller sold 750 shares of The Advisory Board Company stock in a transaction dated Wednesday, April 19th. The shares were sold at an average price of $47.37, for a total transaction of $35,527.50. Following the sale, the insider now directly owns 21,360 shares in the company, valued at approximately $1,011,823.20. The sale was disclosed in a legal filing with the SEC, which is available at this link.

The Advisory Board Company (NASDAQ:ABCO) opened at 51.20 on Friday. The Advisory Board Company has a 12-month low of $24.85 and a 12-month high of $54.50. The stock’s 50 day moving average is $49.01 and its 200 day moving average is $42.33. The stock has a market capitalization of $2.08 billion, a PE ratio of 20.75 and a beta of 1.15.

The Advisory Board Company (NASDAQ:ABCO) last released its quarterly earnings data on Thursday, May 4th. The business services provider reported $0.38 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.26 by $0.12. The firm had revenue of $194.50 million during the quarter, compared to analysts’ expectations of $188.43 million. The Advisory Board Company had a positive return on equity of 11.28% and a negative net margin of 5.77%. The Advisory Board Company’s revenue was down 3.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.44 earnings per share. Equities analysts anticipate that The Advisory Board Company will post $1.96 EPS for the current fiscal year.

Insider Buying and Selling by Quarter for The Advisory Board Company (NASDAQ:ABCO)

TRADEMARK VIOLATION WARNING: This piece was originally posted by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this piece on another domain, it was stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece can be accessed at https://sportsperspectives.com/2017/05/20/the-advisory-board-company-abco-insider-cormac-f-miller-sells-750-shares-2-updated-updated-updated.html.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Howard Hughes Medical Institute acquired a new position in The Advisory Board Company during the first quarter valued at about $158,000. Russell Investments Group Ltd. purchased a new position in shares of The Advisory Board Company during the fourth quarter worth $3,479,000. Two Sigma Investments LP boosted its position in shares of The Advisory Board Company by 938.7% in the fourth quarter. Two Sigma Investments LP now owns 76,882 shares of the business services provider’s stock worth $2,556,000 after buying an additional 69,480 shares in the last quarter. Federated Investors Inc. PA boosted its position in shares of The Advisory Board Company by 30.7% in the fourth quarter. Federated Investors Inc. PA now owns 50,384 shares of the business services provider’s stock worth $1,675,000 after buying an additional 11,837 shares in the last quarter. Finally, Norges Bank purchased a new position in shares of The Advisory Board Company during the fourth quarter worth $12,464,000.

A number of brokerages have recently weighed in on ABCO. Credit Suisse Group AG lifted their target price on shares of The Advisory Board Company from $54.00 to $55.00 and gave the company an “outperform” rating in a research note on Friday, May 5th. TheStreet lowered shares of The Advisory Board Company from a “b-” rating to a “c” rating in a research note on Friday, May 5th. Zacks Investment Research lowered shares of The Advisory Board Company from a “buy” rating to a “hold” rating in a research note on Wednesday, May 10th. Stifel Nicolaus boosted their price objective on shares of The Advisory Board Company from $38.00 to $47.00 and gave the stock a “hold” rating in a research note on Tuesday, January 31st. Finally, JPMorgan Chase & Co. lowered shares of The Advisory Board Company from an “overweight” rating to a “neutral” rating and set a $39.00 price objective on the stock. in a research note on Friday, February 17th. They noted that the move was a valuation call. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and six have issued a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $47.92.

The Advisory Board Company Company Profile

The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The Company offers subscription-based membership programs, software and data-enabled services. All of its programs are rooted in best practices and extends across four areas, including Best practices research, Technology, Data-enabled services and Consulting services.

12 Month Chart for NASDAQ:ABCO

Receive News & Ratings for The Advisory Board Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Advisory Board Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply